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Abstract 
Objectives: Glucagon Like Peptide 2 (GLP-2) is a 33 amino acid peptide hormone released from 
enteroendocrine L-cells following nutrient ingestion. It has been shown to exert trophic effects on the gut. 
We set out to measure GLP-2 concentrations in blood in children with diarrhoea and malnutrition. 
Methods: GLP-2 levels were measured in blood samples collected from five different groups of children 
(n=324) at different time points: (1) those with acute diarrhoea, during illness and 3 weeks after recovery; 
(2) persistent diarrhoea and severe acute malnutrition (SAM); (3) controls contemporaneous for 
diarrhoea; (4) stunted children from the community; (5) controls contemporaneous for the stunted 
children. Stool biomarkers and pathogen analysis was carried out on the children with stunting. 
Results: GLP-2 concentrations were higher during acute diarrhoea (median 3.1 ng/ml, interquartile range, 
IQR 2.1, 4.4) than on recovery (median 1.8, IQR 1.4, 3.1; P=0.001), but were not elevated in children 
with persistent diarrhoea and SAM. In stunted children, there was a progressive decline in GLP-2 levels 
from 3.2 ng/ml (1.9, 4.9) to 1.0 (0.0, 2.0; P<0.001) as the children became more stunted. Measures of 
seasonality (rainfall, temperature, food price index and Shiga toxin-producing Escherichia coli) were 
found to be significantly associated with GLP-2 concentrations in multivariable analysis. We also found a 
correlation between stool inflammatory biomarkers and GLP-2. 
Conclusions: In diarrhoea, GLP-2 levels increased in acute but not persistent diarrhoea. Malnutrition was 
associated with reduced concentrations. GLP-2 displayed seasonal variation consistent with variations in 
nutrient availability.   
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What is known 
 Diarrhoeal disease in children is still a major cause of morbidity and mortality globally 
 Highest rates of diarrhoea-related mortality occur among malnourished children 
 Glucagon-like peptide 2 (GLP-2) is a hormone which can be used to improve intestinal adaptation 
and repair. 
What is new 
 GLP-2 levels in blood rose during acute diarrhoea but not persistent diarrhoea, in which levels 
were similar to healthy controls 
 GLP-2 levels fell progressively in children with stunting 




Diarrhoeal disease and malnutrition continue to contribute significantly to global childhood morbidity and 
mortality. Diarrhoeal disease is the second leading cause of death in children under the age of 5, killing 
around 525 000 children yearly1. In the period 2000-2015, it accounted for 8.6% of the total deaths in 
children aged 1-59 months2. Treatment with oral rehydration solutions, intravenous fluids and zinc has led 
to a reduction in mortality3, but sub-Saharan Africa and Southern Asia continue to have the highest 
numbers of under-5 deaths despite efforts to try and reduce the disease burden4. The majority of diarrhoea 
cases are of acute onset, but 3 - 20% of these cases progress to persistent diarrhoea (PD) which 
contributes disproportionately to morbidity and mortality5,6,7. Diarrhoeal illness is also known to affect 
ponderal and linear growth, especially in cases of recurrent illness8. The problem of diarrhoea is further 
compounded by undernutrition, which is the largest single underlying cause of death among children 
under five9. There is a vicious malnutrition-infection cycle as malnutrition lowers immune function, 
increasing susceptibility to infections which then contribute to undernutrition by reducing energy intake, 
as well as nutrient loss and malabsorption10. Undernutrition may also be exacerbated by the poor living 
conditions which make one more prone to infections and disease. Children living under unsanitary 
conditions tend to have a generalized disturbance of small intestinal structure and function described as 
enteropathy. It has been implicated in growth failure through different mechanisms such as heightened 
permeability, gut inflammation, bacterial translocation and nutrient malabsorption8. Severe enteropathy 
has been observed in children with severe acute malnutrition (SAM) and PD11,12contributing to reduced 
surface area available for nutrient absorption and impaired barrier function13. 
Glucagon Like Peptide-2 (GLP-2) is a 33-amino acid peptide growth factor that is secreted in the lower 
gastrointestinal tract following nutrient ingestion, particularly carbohydrates and lipids 14,15. It was first 
described as „enteroglucagon‟16 in a patient with a renal tumour which induced intestinal hypertrophy. 
GLP-2 is generated via post- translational processing of glucagon and is co-secreted with GLP-1, 
oxyntomodulin, and glicentin in a 1:1:1 ratio 17,18. Once GLP-2 has been released, its effects are mediated 
through the specific binding of the hormone to its receptor, GLP-2R which localizes to enteric neurons 
and endocrine cells19,20. GLP-2 secretion is regulated by nutritional, hormonal and neural factors and it has 
been suggested that many of its actions are exerted indirectly through secondary mediators such as growth 
factors from enteroendocrine, neural and lamina propria cells. Some of its actions include upregulating 
motility, nutrient absorption and cell proliferation while reducing epithelial permeability and apoptosis in 
the gut18,21,22. Post prandial GLP-2 secretion is regulated in a complex manner consisting of both direct 
(via nutrients) and indirect (via endocrine and/or neural) pathways17. Nutrient stimulated GLP-2 release 
has been found to result in a 2 – 5fold increase in plasma levels and as such can easily be detected in fed 
samples23. 
 
We have recently shown that low circulating concentrations of GLP-2 were associated with high levels of 
bacterial translocation, suggesting that impaired secretion may contribute to mucosal dysfunction during 
diarrhoea infection24. The study set out to investigate what changes, if any occur in the levels of GLP-2 in 
children with diarrhoea and malnutrition, and whether GLP-2 release has any link to seasonality, as 




Five different groups of children were studied over the period May 2014 to April 2019. Approval to 
conduct these studies was obtained from the University of Zambia Biomedical Research Ethics 
Committee (UNZABREC). 
Group 1 - Acute Diarrhoea 
28 children with acute diarrhoea, defined as 3 or more loose stools in a 24-hour period (median duration 3 
days, interquartile range (IQR) 2-4) were recruited when they presented to St. Lawrence clinic (Misisi, 
Lusaka). The children were assessed by Integrated Management of Childhood Illness (IMCI) trained 
nurses and managed accordingly25. Informed written consent was obtained from the caregiver, and a 2ml 
blood sample collected at the time of recruitment. The children were then followed up and a convalescent 
blood sample obtained three weeks after the diarrhoea episode ended. UNZABREC approval (007-11-15, 
dated 12th January 2016). 
 
Group 2 – Persistent Diarrhoea 
These children were undergoing treatment in the malnutrition ward of the University Teaching Hospital, 
Lusaka, Zambia. They had PD (diarrhoea for more than 14 days, including skip days, median duration 
21days, IQR 14-28) and SAM(Weight for length/height (WLZ/WHZ) < -3SD and/or mid upper arm 
circumference; MUAC<115mm and/or bilateral pitting oedema of nutritional origin). No pathogens were 
detected on first line investigations (stool microscopy and culture). All the admitted children with SAM 
were managed according to World Health Organisation (WHO) guidelines on inpatient management of 
SAM26. A total of 21 children were recruited and informed written consent obtained from the caregiver. 
Blood samples were collected from the children. UNZABREC approval (006-01-13, dated 15th April 
2013). 
  
Group 3 – Controls for Group 1 & 2 
75 stunted but clinically healthy children were recruited from Misisi compound as contemporaneous 
controls for Groups 1 & 2. They were children who were screened for malnutrition in a previously 
described nutrition outreach programme27. Children from the community were screened for recent 
episodes of diarrhoea (within one month), NSAID use (within one month), antibiotic use (within one 
month) and excluded and treated if needed. These children were selected on the basis that they were not 
acutely malnourished, but 56% had stunting (against a background of 40% stunting across the whole 
country)28 
 
Group 4 – Stunted children 
 5660 children aged 0 to18 months of age, resident in Misisi compound were screened for wasting( 
MUAC <125mm and/or WLZ/WHZ z-score of < –2 SD) and stunting (length/height-for-age (LAZ/HAZ) 
z-score of < –2 SD) in order to identify those with malnutrition  or growth faltering. 297 of those 
identified, were then recruited into a study of biomarkers of environmental enteropathy in children 
(BEECH), provided with nutritional rehabilitation and followed up to the age of 24 months or for a 
minimum of 12 months. Blood samples were collected at recruitment and at 3 months. For those children 
who did not respond to 3 months of nutritional rehabilitation, fed and fasted samples were collected on 
consecutive days. Non-response was defined as lack of improvement in anthropometric 
parameters(WLZ/LAZ/WAZ>-2SD), provided the child had not been ill in this period. Children were 
fasted for at least 4 hours before a sample was collected, as they were being prepared for endoscopy. 
Stool samples were also collected from the children as they came in for their first visit. 181 baseline blood 
samples were tested for GLP-2. UNZABREC approval (006-02-16, dated 3rd January 2018) 
 
  
Group 5 – Controls for Group 4 
Contemporaneous controls (n=46) were recruited for the stunted children to control for the time lapse 
between the studies, as well as temporal changes, seasonal changes and an improvement in stunting from 
40% to 35%28. These children were well nourished (WLZ > -1) and resident in Misisi compound. 19 
baseline blood samples were tested for GLP-2. 
 
Assessment of Nutritional status 
A paediatrician and trained study nurses carried out nutritional status assessment of all the participants 
based on WHO child growth standards29. This was done using anthropometric measurements of mid-
upper arm circumference (MUAC), weight and length/height. The measurements were done using a 
Mother-Child scale (SECA 874, Hamburg Germany) for weight, Infantometers (SECA 416, Hamburg 
Germany) for length, UNICEF height boards for height and MUAC tapes. Raw data were entered into the 
WHO Anthro software v.3.2.230 which then calculated the anthropometry scores. 
 
Measurement of GLP-2, stool markers and stool pathogens 
Plasma samples were tested for GLP-2 by Enzyme Linked Immunosorbent Assay (ELISA) (Millipore 
Corporation, St Charles Missouri, USA). The assay is a sandwich ELISA that only measures total GLP-2.  
 Fecal Myeloperoxidase and Calprotectin were measured as markers of inflammation in children with 
stunting. Myeloperoxidase was measured using the EDI™ Quantitative Fecal/Urine Myeloperoxidase 
ELISA Kit (Epitope diagnostics, Inc. San Diego, USA) and Calprotectin using the IDK® Calprotectin 
ELISA (Immundiagnostik AG, Bensheim, Germany). Both assays utilize the two-site sandwich technique 
with two selected monoclonal antibodies binding to the protein of interest.  
Stool pathogen analysis was done using the qualitative, multiplex polymerase chain reaction (PCR) based 
Luminex x-TAGgastrointestinal pathogen panel (Luminex Corporation, Austin, Texas, USA). This 
assay is able to simultaneously detect 15 enteric pathogens with a sensitivity of 94.3%, for 12 of the 15 
pathogens, and a specificity of 98.5% across all 15 pathogens31. Sample processing and assay conditions 
are described by Chisenga et al32. All the assays were run according to the manufacturer‟s instructions and 
more detail on the assays is provided in Supplemental Digital Content 1 
(http://links.lww.com/MPG/B783). 
Data regarding environmental exposures 
Rainfall and temperature data for the period 2016 – 2018 were obtained from the Lusaka City Airport, 
Zambia Meteorological Office. Food price index (FPI) was obtained from the Jesuit Centre for 
Theological Reflection monthly survey33. This survey details retail costs of basic food items of a family of 
five. It is carried out in different towns and it averages the cost of food based on the prices gathered from 
different places within the town of interest. For the purposes of the paper, the prices indicated were 
averaged from two markets in the vicinity of our study catchment area namely Chawama market and City 
market.  This was to allow us to get more representative costs as averaging it across the costs of the entire 
town would not give a true picture. 
 
Data analysis and statistical considerations 
GLP-2 concentrations in serum were determined to be non-normally distributed using the Shapiro-Wilk 
test, so data are presented as median and interquartile range (IQR). The Kruskal-Wallis test was used for 
hypothesis testing. The Wilcoxon matched-pairs rank sum test was used to test paired samples, and the 
Friedman test for multiple comparisons. Spearman‟s correlation was used to test for correlation between 
GLP-2 and stool inflammatory markers. A p-value less than 0.05 was considered significant.  Univariable 
and multivariable logistic regression analysis was carried out to determine if there was any association 
between GLP-2 concentrations and different variables and pathogens. Pathogen results with numbers less 
than 10 were not included in the final model. Missing data were treated as missing and no imputation was 




324 participants were studied over the course of 5 years.  Groups 1 and 2 were comparable in sex and age 
but not in anthropometry measures (Table 1). The majority of the children from Groups 1, 2 and 3 were 
stunted but those in Group 2 were also wasted.  The control group (Group 3) had not had diarrhoea in the 
month prior to recruitment, were slightly older with more female participants than the other two groups. 
The stunted children (Group 4) were also older than their contemporaneous controls (Group 5). 
 
GLP-2 levels rise in acute diarrhoea but not persistent diarrhoea 
GLP 2 levels in children with acute diarrhoea (Group 1), were elevated during illness and fell after 
convalescence (P=0.001), in all except 5 children (Figure 1A). Circulating GLP-2 concentrations after 
convalescence (median 1.83ng/ml, interquartile range 1.38,3.12) were the same as in the controls (Group 
3) from the same community (median 1.87, IQR 1.40,2.56), confirming that it was the samples taken 
during acute diarrhoea which were elevated (median 3.06ng/ml, IQR 2.09,4.39; Figure 1B). Children with 
PD and SAM (Group 2) had concentrations (median 1.93, IQR 1.28,4.07) which were similar to control 
values (P=0.33) (Figure 1B). 
 
GLP-2 in children with stunting and non-responders 
In Group 4, GLP-2 levels at recruitment (3.2, IQR 1.9,4.9) did not differ from the 3-month visit (3.5, IQR 
2.39,4.83) or controls (3.1, IQR 2.39,4.16), but were significantly lower in the fasted non-responders 
(Figure 2A). GLP-2 in the fasted state was 1.01ng/ml (IQR 0,2.01) and in the fed state was 2.40ng/ml 
(IQR 2.10,3.44). Fed and fasted values were both lower than baseline GLP-2 value (p < 0.001) suggesting 
that the fall in GLP-2 was not merely due to the fasted state (Figure 2B).  
GLP-2 in controls 
In the control groups (groups 3 and 5), GLP-2 concentrations in plasma fell with age ( = -0.35; 
P=0.001). Using an estimate of ß from linear regression the change in GLP-2 over time would be a 
reduction of 0.04 ng/ml per month of increasing age. It is thus very unlikely that the decline in GLP-2 
observed in group 4 could be attributable to age. 
Stool Inflammatory markers 
In the baseline stool samples, median myeloperoxidase stool concentrations were at 102.51ng/ml (IQR 
40.37, 169.68) and calprotectin concentrations at 278.38ug/g(IQR 164.73,619.91). There was a negative 
correlation between GLP-2 and myeloperoxidase (          p = 0.02) and a positive correlation 
between GLP-2 and Calprotectin (      , p = 0.02) 
 
  
GLP-2 shows seasonal pattern 
Seasonal variation has been shown in the prevalence of undernutrition34 and incidence of diarrhoea35. 
Diarrhoeal pathogens have also been shown to vary seasonally, influenced by factors such as rainfall, 
temperature and humidity36. We set out to explore if there is any association between GLP-2 release and 
these factors that vary seasonally i.e. food availability, rainfall, temperature and pathogens. The FPI, 
which covers the cost of food items such as maize meal, beans, kapenta, fish, and vegetables, constituents 
of a typical Zambian meal, was used as a proxy of food availability.  
We found an association between GLP-2 and FPI, temperature and rainfall. There was an increase in 
GLP-2 during the warmer months, and a decrease in GLP-2 when the cost of food was high, and during 
the rainy season. We also looked at whether there was any association between the different pathogens 
detected in stool and GLP-2 release as it has been documented that subclinical carriage of pathogens may 
result in enteropathy37. Intestinal damage from enteropathy may result in a deficiency of hormonal 
response to nutrients. An association was found between GLP-2 and Shiga toxin-producing Escherichia 
coli. Multivariate regression was carried out to confirm these associations (Table 2).  
 
Discussion 
Taken together, our results suggest that GLP2 levels are elevated in acute diarrhoea but not in PD and 
SAM. In children with acute diarrhoea, GLP-2 levels rose and then returned to background levels after 
recovery from infection. This suggests that in cases of acute diarrhoea, the intestinal response to infection 
includes an increase in the amount of circulating GLP-2 which would enhance repair of the damaged 
mucosal epithelium, thereby restoring epithelial integrity. A similar response has also been observed in 
children with intestinal failure38 suggestive of the role GLP-2 plays in enhancing the adaptive response. In 
that study, mean fasted GLP-2 in controls was 11.6ng/ml, and 19.9ng/ml in children with intestinal 
failure. All the children in our study had considerably lower circulating GLP-2 concentrations than 
children in Finland38 but as different ELISA kits were used, the difference noted could be due to 
methodological as well as biological factors. In PD, the reverse of what is occurring in acute diarrhoea 
was observed. It is plausible that in the PD children, SAM plays a major role in the inability of the body 
to respond in a manner similar to that observed in the acute diarrhoea cases. An inability to produce GLP-
2 may perpetuate the malnutrition-infection cycle by impairment of mucosal regeneration, and ultimately 
lead to death in children with SAM.  In stunting, a progressive decline was noted in the children who did 
not respond to nutritional rehabilitation. It appears that malnutrition limits the ability of the gut to respond 
to intestinal damage. What is unknown is whether the enteroendocrine cells that sense these nutrients are 
impaired or have been lost in malnutrition. 
One of the difficulties in interpreting these data is the lack of reference range for young children. 
Progressive increments in GLP-2 concentrations have been noted during early neonatal development and 
the weaning period39. We included two groups of controls to provide a valid comparison. A further 
problem in children is difficulty in ascertaining the fed/fasted state. While we attempted to be clear on this 
point, mothers often use breast feeding to console their children and this may lead to misclassification. 
Composition of feeds also varies widely. 
Intestinal GLP-2 release is nutrient stimulated, so nutrient availability partially determines GLP-2 release. 
We set out to examine whether there is any association between nutrient availability and GLP-2 release. 
We looked at seasonal parameters such as rainfall and temperature, which are known to affect food 
availability. We also took into consideration that the majority of Lusaka residents, very definitely those 
resident in our catchment area, are not farmers, so there is no direct link between produce and food 
availability. The cost of food and other essential household goods affects ones‟ purchasing power, and 
consequently the amount and type of nutrition present in a home. We factored this into our analysis by 
use of the FPI, matching the cost of food at the time the sample was collected, with the amount of GLP-2 
in the sample. Stool pathogens in samples collected over the same time frame were analysed to determine 
if there was any association to GLP-2.  All of the variables stated above were included in a multivariable 
logistic regression model with GLP-2 as the dependent variable.  Rainfall, temperature, FPI and STEC 
showed a significant association with GLP-2, with temperature having a positive correlation coefficient. 
According to WHO, the exposure routes for STEC infection include food, animal contact, human to 
human contact, water and soil40. Based on this, we can conclude that our findings of STEC in baseline 
stool samples are an indication of the levels of environmental contamination present in a population with 
high levels of environmental enteropathy. The levels of the stool markers found in our samples were 
indicative of the levels of gut inflammation present in our cohort.  Both of these markers have been 
studied in relation to environmental enteropathy and malnutrition41,42,43,44,45 with inconsistent results. We 
observed a negative correlation between GLP-2 and myeloperoxidase in our study, indicative of the high 
inflammation present in those with low GLP-2. The reverse was observed in Calprotectin, but this result 
could have been confounded by the age and breastfeeding status of these children46,47. 
Our findings suggest that there is a link between seasonality and GLP-2 release, consistent with its role as 
a nutrient responsive hormone. Teduglutide, a GLP-2 analogue has been successfully used in the 
treatment of IBD, and studies are now underway in severely malnourished children
48 
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Figure 1A: GLP-2 levels in children with acute diarrhoea during illness and 3 weeks after their last 
diarrhoea episode.  
 
Figure 1B: GLP-2 levels in acute and persistent diarrhoea compared to controls 
  
 
Figure 2A: GLP-2 levels in stunted children at baseline, 3 months and prior to endoscopy (fasted non-
responders) compared to healthy controls from the same community. 
 
Figure 2B: Repeated GLP-2 measurements in children designated non-responders at baseline, 3 months, 




Table 1: Baseline characteristics of children  



























Sex: Male, n (%) 
 
17 (66%) 14 (67%) 30 (40%) 107(59%) 6 (32%) 
Age (median IQR)  16.5 (11.5,22) 17 (12,21) 20 (16,29) 11 (7,14) 4 (3,5) 





























































only); stool for 
pathogen 
analysis 
1anthropometric data missing for one healthy control. Group 1 – acute diarrhoea; Group 2 – Persistent 
diarrhoea; Group 3 – Controls for Groups 1 & 2; Group 4 – Stunted children; Group 5 – Controls for 





Table 2: Table of univariable and multivariable logistic regression analysis of GLP-2 concentrations in 
relation to measures of seasonality 
 
 
 Univariable Analysis Multivariable Analysis 
 Variable Coefficient (ß) p(>0.05) Coefficient (ß) p(>0.05) 
Food Price Index -0.002 0.06 -0.002 0.05 
Minimum Temperature 0.029 0.67 0.354 <0.01 
Maximum Temperature 0.177 <0.01   
Rainfall -0.004 <0.01 -0.006 <0.01 
Adenovirus (n=20) -0.642 0.25   
Norovirus (n=104) -0.457 0.22   
Rotavirus (n=41) -0.558 0.16   
Campylobacter (n=78) 0.289 0.83   
Enterotoxigenic Escherichia coli 
(n=117) 
0.485 0.23   
Salmonella (n=135) -0.864 0.86   
Shiga toxin-producing Escherichia 
coli (n=19) 
-1.366 0.02 -1.409 0.01 
Shigella (n=109) 0.025 0.95   
Cryptosporidium spp (n=43) -0.318 0.43   
Giardia (n=116) 0.138 0.73   
